Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-12

Clinical Trial Update: Effects of Dexmedetomidine on Delirium After Living Donor Renal Transplantation in Adult Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of dexmedetomidine on delirium after living donor renal transplantation in adults. The trial status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Tao Zhang | Conditions: Postoperative Delirium After Living Donor Renal Transplantation | Phase 4 | Status: UNKNOWN